What is CIlengitide used for?

CIlengitide is being researched for various types of cancer, including glioblastoma, prostate cancer, melanoma, and lung cancer, as well as some kidney diseases.

Is CIlengitide an oral medication?

The provided data does not specify if CIlengitide is taken by mouth, though it is listed as a protein molecule.

What is the current development stage of CIlengitide?

CIlengitide is in clinical development, with studies reaching up to Phase 3 for certain indications like glioblastoma.

Can CIlengitide be used for brain tumors?

Yes, CIlengitide is being studied for several brain-related conditions such as glioblastoma and cerebral astrocytoma.

Is CIlengitide a natural product?

Yes, CIlengitide is classified as a natural product.

Cilengitide | CAS 188968-51-6 | AMLYAMJWYAIXIA

Loading compound...

Integrin antagonist

CIlengitide is a protein-based drug currently being studied in clinical trials. It works by blocking specific proteins called integrin alpha-V/beta-3 and alpha-V/beta-5, which are involved in how certain cells behave.

How it worksCIlengitide acts as an antagonist to integrin alpha-V/beta-3 and alpha-V/beta-5, meaning it blocks these specific targets in the body.

Used for

Glioblastoma multiformeProstate cancerCerebral astrocytomaGliosarcomaCentral nervous system cancerAnaplastic astrocytomaAnaplastic oligodendrogliomaNon-small cell lung carcinomaMelanomaSarcomaChronic myeloproliferative disorderKidney diseaseDiffuse intrinsic pontine gliomaCentral nervous system neoplasmsMyelodysplastic syndrome

Conditions

GlioblastomaProstate cancerMelanomaLung cancerKidney disease

Class

Integrin antagonistProteinCentral Nervous SystemRenal

How to take

CIlengitide is currently in various stages of clinical research (Max Phase 1.0 to 3.0) and is not yet a standard approved treatment for these conditions in all cases.

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-25.

How to take

Frequently asked questions (6)